Buying Indian generic medicines across borders is one of the smartest ways to cut long-term healthcare costs, but the process is only smooth when you understand the customs, documentation and…
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has granted AstraZeneca permission to market its HER2-targeting cancer therapy Enhertu (trastuzumab deruxtecan) for a new, expanded breast cancer indication,…
India is known as the "Pharmacy of the World" for its low-cost generic medicines, but a quieter revolution is underway in a different category: biosimilars. These are near-copies of complex…
India's pharmaceutical sector is widely expected to miss its 2030 sales target, as a combination of US import tariffs on generic drugs and prolonged shipping disruptions weigh on export momentum.…